Add To Watchlist
Share URL
About The Company
Description
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women.
Read More
Overview
Value
67
Growth
72
Health
71
Management
63
Analyst Opinion
86
Total
72
All Scores Out Of 100
Best Features
- Very strong cashflow and earnings growth
- Has a low level of debt
- Has a history of share buybacks
- Low risk of bankruptcy
- Has strong financial health
- Price-to-earnings ratio of 13.7 is lower than the market average (19.6x)
- Liked by analysts
- Low preportion of income is paid as dividend 0
Risk Factors
- Earnings have declined recently
Market Peers
HO1.DE
Key Figures
PE Ratio (TTM)
13.74
Margin Of Safety (DCF)
N/A
Revenue Growth (5 Year Average)
14.43%
Ratings Consensus
Strong Buy
Share Buybacks
1.14%
Dividend Yeild (TTM)
N/A
Valuation
Value Score
67
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Buy Target: N/ANaNNaN
Current Price: 65.3 EUR
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.
Price/Earnings
13.74x
Free Cashflow Yeild
N/A
PE/Earnings Growth
N/A
Price/Book
Infinityx
Growth
Growth Score
72
- ✔ 5 Year Average Revenue growth of 14.43% is higher than the market average (10.97%)
- ✔ 5 Year Average Earnings growth of 24.49% is higher than the market average (14.48%)
- ✔ 5 Year Average Cashflow growth of 19.62% is higher than the market average (12.35%)
- ✘ Revenue growth has slowed this year
- ✘ Earnings growth has slowed this year
- ✘ Free Cashflow growth has slowed this year
Revenue Growth
14.43%
Earnings Growth
24.49%
Cashflow Growth
19.62%
Health
Health Score
71
Altman Z Score
4.14
Piostroski Score
6.00
Debt/Equity
0.58x
Current Assets/Liabilities
4.12x
Free Cashflow/Total Debt
0.71x
Debt/Capital
0.73x
Management
Management Score
63
Average Buybacks/Dilution
1.14%
Recent Buybacks/Dilution
-100.00%
5 Year Price Volitility
15.86%
Return On Assets
N/A
Return On Capital Employed
25.41%
Return On Equity
N/A
Return On Free Cashflow
N/A
Return On Investments
N/A
Analysts
Analyst Opinion
86
- ✔ Ratings consensus is Strong Buy
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
Other Information
Company Name
Hologic Inc
Currency
EUR
Beta
1.41088
Vol Avg
33
Ceo
Mr. Stephen MacMillan
Cik
Cusip
Exchange
XETRA
Full Time Employees
6478
Industry
Health Care Equipment & Services
Sector
Healthcare
Ipo Date
1990-03-01
Address
250 Campus Dr
City
Marlborough
State
MASSACHUSETTS
Country
US
Zip
Phone
15082632900
All financial data provided by FMP